| Literature DB >> 24195643 |
Huan-Ji Dong1, Ewa Wressle, Jan Marcusson.
Abstract
BACKGROUND: As life expectancy continues to rise, more elderly are reaching advanced ages (≥80 years). The increasing prevalence of multimorbidity places additional demands on health-care resources for the elderly. Previous studies noted the impact of multimorbidity on the use of health services, but the effects of multimorbidity patterns on health-service use have not been well studied, especially for very old people. This study determines patterns of multimorbidity associated with emergency-room visits and hospitalization in an 85-year-old population.Entities:
Mesh:
Year: 2013 PMID: 24195643 PMCID: PMC3840694 DOI: 10.1186/1471-2318-13-120
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Characteristics of the participants
| Type of housing, n (%) | | | 0.079 (χ2 = 3.08, df = 1) a | φc = 0.079 |
| Ordinary housing | 174 (92) | 267 (87) | | |
| Sheltered accommodation/Nursing home | 15 (8) | 40 (13) | | |
| Marital status, n (%) | | | <0.001(χ2 = 56.78, df = 1) a | φc = 0.34 |
| Married/Cohabitated | 142 (75) | 124 (40) | | |
| Widowed/Divorced/Unmarried | 47 (25) | 183 (60) | | |
| Living situation, n (%) | | | <0.001 (χ2 = 61.17, df = 1) a | φc = -0.35 |
| Alone | 68 (36) | 220 (72) | | |
| With others | 121 (64) | 87 (28) | | |
| Level of education, n (%) | | | <0.001(χ2 = 6.57, df = 1) a | φc = -0.18 |
| ≤ 7 years | 97 (52) | 188 (64) | | |
| > 7 years | 89 (48) | 106 (36) | | |
| Working status, n (%) | | | 0.004 (χ2 = 10.83, df = 2) a | φc = -0.15 |
| Low (blue collar) | 81(44) | 174(59) | | |
| Intermediate (white collar) | 85(46) | 103(35) | | |
| High (self-employed or academic profession) | 17(9) | 16(6) | | |
| Use of assistive technology, n (%) | 80 (43) | 212 (70) | <0.001(χ2 = 34.33, df = 1) a | φc = 0.26 |
| No. of used assistive technology, Median, (IQR) | 0 (0–2) | 2 (0–3) | <0.001(U = 20 116, df = 490) b | rrb = 0.26 |
| Assistance needed, n (%) | 75 (40) | 209 (68) | <0.001 (χ2 = 37.11, df = 1) a | φc = 0.28 |
| No. of used assistance service, Median, (IQR) | 0 (0–1) | 1 (1–2) | <0.001(U = 19 001, df = 488) b | rrb = 0.3 |
| Self-rated Health (range 0–100), Mean ± SD | 69 ± 19 | 65 ± 20 | 0.018 (t = -2.37, df = 435) c | Cohen’s d = 0.21 |
| No. of GP visits, Median (IQR) | 1 (0–3) | 2 (1–3) | 0.057 (U = 26 119, df = 494) b | rrb = 0.09 |
| Any visit to ER, n (%) | 55 (31) | 95 (29) | 0.664 (χ2 = 0.19, df = 1) a | φc = 0.02 |
| Any in-patient hospitalization, n (%) | 44 (25) | 79 (23) | 0.539 (χ2 = 0.38, df = 1) a | φc = 0.03 |
GP, General practitioner; ER, Emergency Room;
Number of subjects, % of subjects, means with standard deviations (SD), and median with interquartile range (IQR) of variables are shown.
a Pearson Chi-square, b Mann–Whitney U Test; c Student’s t test; φc: Cramér’s phi; rrb: rank-biserial correlation coefficient r.
Prevalence of diagnosed chronic diseases (n = 496)
| Hypertension | 250 (50.4) | 97 (51.3) | 153 (49.8) | 0.748 (χ2 = 0.10) |
| Hyperlipidemia | 107 (21.6) | 53 (28) | 54 (17.6) | 0.006 (χ2 = 7.56) |
| Urinary incontinence | 103 (20.8) | 19 (10.1) | 84 (27.4) | <0.001 (χ2 = 21.3) |
| Arrhythmia | 78 (15.7) | 29 (15.3) | 49 (16) | 0.115 (χ2 = 0.03) |
| Heart failure | 75 (15.1) | 33 (17.5) | 42 (13.7) | 0.254 (χ2 = 1.30) |
| Diabetes | 75 (15.1) | 27 (14.3) | 48 (15.6) | 0.684 (χ2 = 0.17) |
| Stroke | 58 (11.7) | 23 (12.2) | 35 (11.4) | 0.796 (χ2 = 0.07) |
| Myocardial infarction | 55 (11.1) | 30 (15.9) | 25 (8.1) | 0.008 (χ2 = 7.09) |
| Affective diseases | 60 (12.1) | 14 (7.4) | 46 (15) | 0.012 (χ2 = 6.32) |
| Malignancy | 50 (10.1) | 28 (14.3) | 22 (7.2) | 0.006 (χ2 = 7.48) |
| Asthma or COPD | 45 (9.1) | 20 (10.6) | 25 (8.1) | 0.358 (χ2 = 0.84) |
| Osteoarthritis | 39 (8.3) | 11 (5.8) | 28 (9.8) | 0.185 (χ2 = 1.76) |
| Thrombosis or PVD | 35 (7.1) | 14 (7.9) | 21 (6.5) | 0.811 (χ2 = 0.06) |
| Dementia | 33 (6.7) | 7 (3.7) | 26 (8.5) | 0.039 (χ2 = 4.28) |
| Thyroid dysfunction | 33 (6.7) | 8 (4.2) | 25 (8.1) | 0.09 (χ2 = 2.88) |
| Osteoporosis | 24 (4.8) | 1 (0.5) | 23 (7.5) | <0.001 (χ2 = 12.32) |
| Multimorbidity (≥2 chronic diseases) | 339 (68.3) | 134 (70.8) | 205 (66.8) | 0.338 (χ2 = 0.92) |
COPD, Chronic Obstructive Disease; PVD, Periphery Vascular Disease.
Data were analyzed using Chi-square, df =1.
Figure 1Men’s morbidity clusters. In the tree diagram, the distance between two clusters (or variables) is calculated according to the measure of similarity (Yule’s Q) and the cluster algorithm (average linkage between groups). The shorter the distance, the closer are the clusters. Three to five clusters are obtained by shifting the cut-off (vertical line) between Q values of 0.2 and 0.3. We evaluate that a five-cluster solution identifies most clinically meaningful multi-morbidity. The agglomerative coefficients given to the terminal node in each cluster are: Cluster 1, 0.317 (OR 1.9); Cluster 2, 0.587 (OR 3.8); Cluster 3, 0.62 (OR 4.3); Cluster 4, 0.581 (OR 3.8); Cluster 5, 0.393 (OR 2.3).
Figure 2Women’s morbidity clusters. Four to six clusters are obtained by shifting the cut-off (vertical line) between Q values of 0.2 and 0.3. We evaluate that a five-cluster solution identifies most clinically meaningful multi-morbidity. The agglomerative coefficients given to the terminal node in each cluster are: Cluster 1, 0.393 (OR 2.3); Cluster 2, 0.557 (OR 3.5); Cluster 3, 0.244 (OR 1.6); Cluster 4, 0.45 (OR 2.6); Cluster 5, 0.619 (OR 4.3).
Association of single morbidity and morbidity clusters with ER visits in men
| Predictors | OR (95% CI); | Predictors | OR (95% CI); |
| Heart failure | 2.4 (1–5.7); 0.043 | Cluster 4 | 1.6 (1–2.5); 0.036 |
| No. of GP visits | 1.3 (1.1-1.5); 0.006 | No. of GP visits | 1.3 (1.1-1.5); 0.004 |
| Nagelkerke R2 | 0.135 | Nagelkerke R2 | 0.11 |
Odds Ratios (ORs) with 95% Confidence Intervals (CI) in parentheses and p-value are shown.
Cluster4: hyperlipidemia, myocardial infarction, and arrhythmia.
Predictors excluded in model 1: type of housing, marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, thrombosis/PVD, stroke, diabetes, hypertension, COPD/asthma, urinary incontinence, affective disorder, myocardial infarction, hyperlipidemia, arrythmia, malignancy, and osteoarthritis.
Predictors excluded in model 2: type of housing, marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, Cluster 1, Cluster 2, Cluster 3 and Cluster 5.
Association of single morbidity and morbidity clusters with ER visits in women
| Predictors | OR (95% CI); | Predictors | OR (95% CI); |
| Low working status | reference | Cluster 3 | 1.5 (1.1-2); 0.021 |
| Middle working status | 2.2 (1.1-4.1); 0.018 | No. of GP visits | 1.4 (1.2-1.6); <0.001 |
| High working status | 3.5 (1.1-11.3); 0.036 | | |
| Heart failure | 3 (1.3-6.9); 0.01 | | |
| Arrhythmia | 2.2 (1–4.8); 0.05 | | |
| Diabetes | 0.3 (0.1-0.9); 0.027 | | |
| No. of GP visits | 1.3 (1.1-1.6); <0.001 | | |
| Nagelkerke R2 | 0.219 | Nagelkerke R2 | 0.143 |
Odds Ratios (ORs) with 95% Confidence Intervals (CI) in parentheses and p-value are shown.
GP: General Practioner;
Cluster3: myocardial infarction, arrhythmia, heart failure, COPD/asthma, and osteoporosis.
Predictors excluded in model 1: type of housing, marital status, level of education, no. of used assistive tecknology, no. of used assistance service, self-rated health, hyperlipidemia, thrombosis/PVD, hypertension, stroke, urinary incontinence, osteoarthritis, myocardial infarction, COPD/asthma, osteoporosis, malignancy, thyroid dysfunction, dementia, and affective disorder.
Predictors excluded in model 2: type of housing, marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, Cluster 1, Cluster 2, Cluster 4, and Cluster 5.
Association of single morbidity, morbidity clusters, and cluster interactions with hospitalization in men
| Predictors | OR (95% CI); | Predictors | OR (95% CI); | Predictors | OR (95% CI); |
| No. of used assistive technology | 1.6 (1.2-2); <0.001 | No. of used assistive technology | 1.6 (1.3-2); <0.001 | No. of used assistive technology | 1.6 (1.2-2); <0.001 |
| No. of GP visits | 1.2 (1.0-1.5); 0.028 | No. of GP visits | 1.2 (1.0-1.5); 0.032 | No. of GP visits | 1.2 (1.0-1.5); 0.049 |
| | | Cluster 4 | 1.6 (1.0-2.7); 0.048 | Cluster 2* Cluster 4 | 1.6 (1.0-2.4); 0.042 |
| Nagelkerke R2 | 0.188 | Nagelkerke R2 | 0.219 | Nagelkerke R2 | 0.22 |
Odds Ratios (ORs) with 95% Confidence Intervals (CI) in parentheses and p-values are shown.
GP, General practitioner;
Cluster 2: heart failure, asthma/COPD; Cluster 4: hyperlipidemia, myocardial infarction, and arrhythmia;
Predictors excluded in model 1: type of housing, marital status, level of education, working status, no. of used assistance service, self-rated health, thrombosis/PVD, stroke, diabetes, hypertension, heart failure, COPD/asthma, urinary incontinence, affective disorder, myocardial infarction, hyperlipidemia, arrythmia, malignancy, and osteoarthritis.
Predictors excluded in model 2: type of housing, marital status, level of education, working status, no. of used assistance service, self-rated health, Cluster 1, Cluster 2, Cluster 3, and Cluster 5.
Predictors excluded in model 3: type of housing, marital status, level of education, working status, no. of used assistance service, self-rated health, Cluster 1, Cluster 2, Cluster 3, Cluster 4, Cluster 5, Cluster 1*Cluster 4, Cluster 3*Cluster 4, Cluster 5*Cluster 4.
Association of single morbidity, morbidity clusters, and cluster interactions with hospitalization in women
| Predictors | OR (95% CI); | Predictors | OR (95% CI); | Predictors | OR (95% CI); |
| No. of GP visits | 1.4 (1.2-1.6); <0.001 | No. of GP visits | 1.3 (1.1-1.6); <0.001 | Sheltered accommodation/ Nursing home | 2.5 (1.0-5.9); 0.044 |
| Heart failure | 3.4 (1.6-7.3); 0.002 | Cluster 2 | 0.4 (0.2-0.8); 0.006 | No. of GP visits | 1.4 (1.2-1.6); <0.001 |
| Urinary incontinence | 0.4 (0.2-0.8); 0.012 | Cluster 3 | 1.7 (1.2-2.4); 0.004 | Cluster 3 | 2.3 (1.5-3.5); <0.001 |
| | | | | Cluster 2* Cluster 3 | 0.5 (0.3-0.8); 0.005 |
| Nagelkerke R2 | 0.19 | Nagelkerke R2 | 0.193 | Nagelkerke R2 | 0.213 |
Odds Ratios (ORs) with 95% Confidence Intervals (CI) in parentheses and p-values are shown.
GP, General practitioner;
Cluster 2: incontinence, osteoarthritis; Cluster 3: myocardial infarction, arrhythmia, heart failure, asthma/COPD, and osteoporosis.
Predictors excluded in model 1: type of housing, marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, malignancy, hypertension, myocardial infarction, arrythmia, hyperlipidemia, COPD/asthma, diabetes, dementia, affective disorder, thyroid dysfunction, osteoporosis, osteoarthritis, thrombosis/PVD, and stroke.
Predictors excluded in model 2: type of housing, marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, Cluster 1, Cluster 4, and Cluster 5.
Predictors excluded in model 3: marital status, level of education, working status, no. of used assistive tecknology, no. of used assistance service, self-rated health, Cluster 1, Cluster 2, Cluster 4, Cluster 5, Cluster 1*Cluster 2, Cluster 4* Cluster 2, Cluster 5* Cluster 2, Cluster 1* Cluster 3, Cluster 4*Cluster 3, Cluster 5*Cluster 3.